Scientech Research LLC Protagonist Therapeutics, Inc Transaction History

Scientech Research LLC

  • $287 Billion
  • Q3 2025

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 15, 2025
BUY
$35.09 - $59.76 $218,154 - $371,527
6,217 Added 51.58%
18,271 $884 Million
Q4 2024

Feb 14, 2025
SELL
$38.51 - $48.43 $95,235 - $119,767
-2,473 Reduced 17.02%
12,054 $465 Million
Q3 2024

Nov 14, 2024
BUY
$33.72 - $47.33 $489,850 - $687,562
14,527 New
14,527 $654 Million

Others Institutions Holding PTGX

# of Institutions
294
Shares Held
66.9M
Call Options Held
139K
Put Options Held
40.7K
View Full List

About Protagonist Therapeutics, Inc

PTGX Quotes by TradingView
  • Ticker PTGX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 49,084,100
  • Market Cap $4.15B
  • Description
  • Protagonist Therapeutics, Inc., a biopharmaceutical company, discovers and develops peptide-based therapeutic drugs to address hematology and blood disorders, and inflammatory and immunomodulatory diseases. It is developing rusfertide (PTG-300), an injectable hepcidin mimetic that is in Phase II clinical trials for the treatment of patients with...
More about PTGX
Track This Portfolio

Track Scientech Research LLC Portfolio

Follow Scientech Research LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Scientech Research LLC, based on Form 13F filings with the SEC.

News

Stay updated on Scientech Research LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email